Skip to main content
. 2021 Feb 1;12:642877. doi: 10.3389/fneur.2021.642877

Table 1.

Baseline characteristics for patients with an A-shaped SVS compared to those with an S-shaped SVS (S-SVS).

All S-SVS A-SVS p-value
Number of patients 62/62 (100%) 27/62 (44%) 35/62 (56%)
Age, years (median, IQR) 70 (57–77) 72 (63–79) 67 (55–76) 0.960
Female (%) 33 (53%) 14 (52%) 19 (54%) 1.000
Medical history
  Hypertension (%) 44 (71%) 18 (67%) 26 (74%) 0.51
  Diabetes (%) 16 (26%) 8 (30%) 8 (23%) 0.41
  Hyperlipidemia 30 (48%) 11 (41%) 19 (54%) 0.33
  Atrial fibrillation (%) 31 (50%) 15 (56%) 16 (46%) 0.34
  Coronary artery disease (%) 13 (21%) 6 (22%) 7 (20%) 0.49
  Prior stroke (%) 8 (13%) 3 (11%) 5 (14%) 0.71
  Platelets 195 (163–228) 207 (171–240) 179 (161–212) 0.15
Smoking 0.16
  Never (%) 35 (57%) 17 (63%) 18 (51%)
  Prior (%) 19 (31%) 9 (33%) 10 (29%)
  Current (%) 8 (13%) 1 (4%) 7 (20%)
Stroke details
  Baseline NIHSS (median, IQR) 16 (12–21) 14 (10–20) 17 (13–22) 0.12
  Drugs and medications
  Antiplatelet or anticoagulant 28 (45%) 15 (56%) 13 (36%) 0.15
  Intravenous tPA (%) 40 (65%) 18 (67%) 22 (63%) 0.48